Acronym Algae4IBD
Category
Marine Biotechnology
Title Algae4IBD: From Nature To Bedside - Algae Based Bio Compound For Prevention And Treatment Of Inflammation, Pain and IBD Programme H2020
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source European Coordinator Dorit Avni Coordinator email dorita@migal.org.il
Coordinator institution
MIGAL - Migal Galilee Research Institute (Israel)
Institutions involved
NA - ALGAIA (France) ,
CCMAR-Algarve - Algarve Centre of Marine Sciences (Portugal) ,
BRC - Biological Research Centre Szeged (Hungary) ,
NA - ELOOP Srl (Italy) ,
NA - ENCO Srl (Italy) ,
ç - European Science Communication Institute (Germany) ,
VITO - Flemish Institute for Technological Research (Belgium) ,
Hunimed - Humanitas University (Italy) ,
NA - Institute of Microbiology of the Czech Academy of Sciences (Czech Republic) ,
IMG - Institute of Molecular Genetics of the Czech Academy of Sciences (Czech Republic) ,
OSR - IRCCS San Raffaele Hospital (Italy) ,
NA - Necton - Companhia Portuguesa de Cultura Marinhas SA (Portugal) ,
UIN - Nord University (Norway) ,
NA - Sea4Us (Portugal) ,
NA - Slovak University of Agriculture in Nitra (Slovakia) ,
NA - Solaris Lab Srl (Italy) ,
NA - Synovo GmbH (Germany) ,
NA - Teagasc Food Research Centre (Ireland) ,
UNINA - University of Naples Federico II (Italy) ,
NA - Yemoja Microalgae Re-evolution Ltd (Israel) ,
Start year 2021 End year 2025 Funding (€) € 7,499,520 Website https://algae4ibd.eu/ Summary What is the solution for a chronic disease lies in our ocean, rivers, or lakes? The EU-funded Algae4IBD project will answer this question. Studying compounds from marine and freshwater micro and macroalgae (seaweed) from lab/pilot to market scale, the project will comprehensively research means to transform aquatic natural biological resources into biologically active compounds for the prevention and treatment of inflammatory bowel disease (IBD). Specifically, it will develop algae-based compounds while ensuring algae biodiversity preservation through pioneering cultivation and extraction technologies. Algae4IBD proposes innovative solutions to sustainably use algae-based products with improved nutritional quality to positively impact IBD patients.
Keywords
Algae;
Human health;
Bioprospecting;
Bioactive compounds;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
